A meta-analysis of combination therapy versus single-agent therapy in anthracycline- and taxane-pretreated metastatic breast cancer: results from nine randomized Phase III trials

Nowadays, the philosophy of treating metastatic breast cancer (MBC) is slowly evolving. Especially for the anthracycline- and taxane-pretreated MBC patients, no standard therapy exists in this setting. Whether to choose doublet agents or single agent as salvage treatment remains fiercely debated. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Liang, Wu, Xiaobo, Hu, Chun, Zhang, Zhiying, Zhang, Le, Liang, Shujing, Xu, Yingchun, Zhang, Fengchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938138/
https://www.ncbi.nlm.nih.gov/pubmed/27445497
http://dx.doi.org/10.2147/OTT.S101423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938138/
https://www.ncbi.nlm.nih.gov/pubmed/27445497
http://dx.doi.org/10.2147/OTT.S101423

Ejemplares similares